A recent MM+M article, authored by Fannie McWatt and Adriano Botter, examines how AI is shifting from a marketing tool to an active “audience,” changing how brands compete for visibility, credibility, and influence in AI-driven decision-making environments.

Payer Sciences ranks #66 on MM+M’s 2026 Agency 100 list, recognized for its specialized market access expertise and ability to turn complex payer insights into actionable strategy. By combining analytics, AI, and a deeply integrated Publicis Health model, the agency is helping brands navigate access challenges and drive smarter, more effective healthcare decisions.

P-value Group makes its debut on MM+M’s 2026 Agency 100 list, earning a spot at #56 and signaling a pivotal moment of growth and transformation. By pairing its scientific rigor with expanded AI and data capabilities through Publicis Health, the agency is elevating how tailored, high-impact medical communications reach healthcare professionals.

Saatchi & Saatchi Health lands at #50 on MM+M’s 2026 Agency 100 list, recognized for its bold blend of creativity, AI-driven innovation, and audience-first thinking. By combining storytelling, data, and modern engagement strategies, the agency is helping healthcare brands build more meaningful, real-world connections.

Heartbeat earns the #48 spot on MM+M’s 2026 Agency 100 list, recognized for its bold, challenger-brand mindset and emotionally driven approach to healthcare marketing. By blending data, strategy, and creative disruption, the agency continues to help brands break through in complex and competitive categories.

Razorfish Health secures the #47 spot on MM+M’s 2026 Agency 100 list, recognized for its science-first approach and growing impact across medical communications, data innovation, and high-science engagements. With continued investment in AI and the launch of Publicis Health Core Medical, the agency is redefining how complex science translates into meaningful, human-centered healthcare experiences.

Digitas Health earns the #19 spot on MM+M’s 2026 Agency 100 list, recognized for its continued evolution into a creative-first, data-driven powerhouse. By blending strategy, media, and innovation across the Publicis Health network, the agency is redefining how meaningful, human-centered healthcare marketing comes to life.

AI-generated human imagery is reshaping pharmaceutical marketing, offering new opportunities for scale and efficiency while raising the stakes for authenticity, governance, and patient trust. The challenge is no longer whether to use AI, but how to apply it responsibly.

Matt McNally discusses his return to Publicis Health, the network’s recent growth, and what’s ahead for healthcare marketing in 2026. In the MM+M podcast interview, McNally also shares insights on leadership and the evolving industry landscape.